Abstract

Immune Predictors of Response to Pembrolizumab Monotherapy As Consolidation in Multiple Myeloma Patients: Results of the GEM-Pembresid Clinical Trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Worldwide Examination of Patients with CLL Hospitalized for COVID-19
...
Blood | VOL. 136
, et. al. ...
05 Nov 2020
Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study
...
Blood | VOL. 132
, et. al. ...
29 Nov 2018
Safety of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome: Final Results from the Phase 3 Mavoric Study
Youn H Kim ...
Blood | VOL. 134
Youn H Kim, et. al.Youn H Kim ...
13 Nov 2019
Efficacy and Safety of Front-Line Venetoclax and Rituximab (VenR) for the Treatment of Young Patients with Chronic Lymphocytic Leukemia and an Unfavorable Biologic Profile. Preliminary Results of the Gimema Study ‘Veritas‘
Francesca Romana Mauro ...
Blood | VOL. 136
Francesca Romana Mauro, et. al.Francesca Romana Mauro ...
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Magisetty J, Kondreddy V, Keshava S, et al. Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice. Blood. 2022;139(18):2830-2841.
-
Blood | VOL. 144
--
01 Aug 2024
Human herpesvirus 6 and CAR T-cell toxicity
Karl S Peggs
Blood | VOL. 144
Karl S PeggsKarl S Peggs
01 Aug 2024
Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold stored platelets.
Shailaja Hegde ... Jose Cancelas
Blood | VOL. -
Shailaja Hegde, et. al.Shailaja Hegde ... Jose Cancelas
01 Aug 2024
EPCR shedding light on sickle nephropathy
Erica M Sparkenbaugh
Blood | VOL. 144
Erica M SparkenbaughErica M Sparkenbaugh
01 Aug 2024
View more papers